Healthcare and life-science investment firm Decheng Capital is looking to raise $700 million for its fifth fund in what could become the firm’s largest vehicle to date, according to a filing with the US Securities and Exchange Commission (SEC).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
